Medical management of fistulising Crohn's disease

Tidsskr Nor Laegeforen. 2019 Jan 9;139(1). doi: 10.4045/tidsskr.17.1055. Print 2019 Jan 15.
[Article in English, Norwegian]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / physiopathology
  • Drug Therapy, Combination
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Rectal Fistula / drug therapy*
  • Rectal Fistula / etiology
  • Rectal Fistula / physiopathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Bacterial Agents
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha